Titre : Régulon

Régulon : Questions médicales fréquentes

Termes MeSH sélectionnés :

Surveys and Questionnaires
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régulon : Questions médicales les plus fréquentes", "headline": "Régulon : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régulon : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-26", "dateModified": "2025-03-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régulon" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composants de génome", "url": "https://questionsmedicales.fr/mesh/D040481", "about": { "@type": "MedicalCondition", "name": "Composants de génome", "code": { "@type": "MedicalCode", "code": "D040481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024" } } }, "about": { "@type": "MedicalCondition", "name": "Régulon", "alternateName": "Regulon", "code": { "@type": "MedicalCode", "code": "D018085", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bernhard O Palsson", "url": "https://questionsmedicales.fr/author/Bernhard%20O%20Palsson", "affiliation": { "@type": "Organization", "name": "Department of Bioengineering, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Ye Gao", "url": "https://questionsmedicales.fr/author/Ye%20Gao", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Yara Seif", "url": "https://questionsmedicales.fr/author/Yara%20Seif", "affiliation": { "@type": "Organization", "name": "Department of Bioengineering, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Doron Teper", "url": "https://questionsmedicales.fr/author/Doron%20Teper", "affiliation": { "@type": "Organization", "name": "Citrus Research and Education Center, Department of Microbiology and Cell Sciences, University of Florida, 700 Experiment Station Road, Lake Alfred FL 33850, U.S.A." } }, { "@type": "Person", "name": "Nian Wang", "url": "https://questionsmedicales.fr/author/Nian%20Wang", "affiliation": { "@type": "Organization", "name": "Citrus Research and Education Center, Department of Microbiology and Cell Sciences, University of Florida, 700 Experiment Station Road, Lake Alfred FL 33850, U.S.A." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Current treatment status of IgA nephropathy in Japan: a questionnaire survey.", "datePublished": "2023-08-30", "url": "https://questionsmedicales.fr/article/37646957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10157-023-02396-0" } }, { "@type": "ScholarlyArticle", "name": "Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan.", "datePublished": "2024-09-10", "url": "https://questionsmedicales.fr/article/39251506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00520-024-08858-9" } }, { "@type": "ScholarlyArticle", "name": "[The Questionnaire Survey of Japanese Practice and Environment for Targeted Radionuclide Therapy in 2021].", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36696976", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.6009/jjrt.2023-1317" } }, { "@type": "ScholarlyArticle", "name": "Sequential dependencies of responses in a questionnaire survey and their effects on the reliability and validity of measurement.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36085546", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3758/s13428-022-01943-z" } }, { "@type": "ScholarlyArticle", "name": "Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.", "datePublished": "2024-11-01", "url": "https://questionsmedicales.fr/article/39486019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/64159" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Régulon", "item": "https://questionsmedicales.fr/mesh/D018085" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régulon - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régulon", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régulon", "description": "Comment savoir si le Régulon est adapté ?\nQuels tests sont nécessaires avant de commencer le Régulon ?\nLe Régulon nécessite-t-il un suivi médical ?\nQuels signes indiquent une mauvaise tolérance au Régulon ?\nLe Régulon est-il efficace dès le premier jour ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Surveys+and+Questionnaires&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régulon", "description": "Quels sont les effets secondaires courants du Régulon ?\nLe Régulon peut-il provoquer des douleurs abdominales ?\nComment reconnaître une réaction allergique au Régulon ?\nLe Régulon peut-il affecter l'humeur ?\nQuels symptômes nécessitent d'arrêter le Régulon ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Surveys+and+Questionnaires&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régulon", "description": "Comment le Régulon prévient-il la grossesse ?\nLe Régulon est-il efficace pour réguler le cycle menstruel ?\nQuels conseils pour maximiser l'efficacité du Régulon ?\nLe Régulon peut-il être utilisé comme traitement hormonal ?\nEst-il nécessaire de consulter un médecin avant de commencer le Régulon ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Surveys+and+Questionnaires&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régulon", "description": "Comment prendre le Régulon correctement ?\nQue faire en cas d'oubli d'une pilule ?\nLe Régulon peut-il être pris avec d'autres médicaments ?\nCombien de temps peut-on prendre le Régulon ?\nLe Régulon protège-t-il contre les IST ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Surveys+and+Questionnaires&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régulon", "description": "Quelles sont les complications possibles du Régulon ?\nComment reconnaître un caillot sanguin lié au Régulon ?\nLe Régulon augmente-t-il le risque de cancer ?\nQuels signes d'AVC doivent alerter ?\nLe Régulon peut-il causer des problèmes de foie ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Surveys+and+Questionnaires&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régulon", "description": "Qui devrait éviter le Régulon ?\nLe tabagisme influence-t-il l'utilisation du Régulon ?\nLes femmes obèses doivent-elles être prudentes avec le Régulon ?\nLes antécédents familiaux de cancer influencent-ils le choix ?\nLe Régulon est-il sûr pour les femmes âgées ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Surveys+and+Questionnaires&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment savoir si le Régulon est adapté ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un médecin évalue l'historique médical et les besoins contraceptifs." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant de commencer le Régulon ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique et éventuellement des tests sanguins pour vérifier la santé." } }, { "@type": "Question", "name": "Le Régulon nécessite-t-il un suivi médical ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi est recommandé pour évaluer l'efficacité et les effets secondaires." } }, { "@type": "Question", "name": "Quels signes indiquent une mauvaise tolérance au Régulon ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des saignements irréguliers ou des nausées persistantes." } }, { "@type": "Question", "name": "Le Régulon est-il efficace dès le premier jour ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est efficace immédiatement si pris au début du cycle menstruel." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants du Régulon ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, maux de tête, changements d'humeur et saignements irréguliers." } }, { "@type": "Question", "name": "Le Régulon peut-il provoquer des douleurs abdominales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines femmes peuvent ressentir des douleurs abdominales légères." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique au Régulon ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, éruptions cutanées ou gonflements peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Le Régulon peut-il affecter l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements d'humeur peuvent survenir en raison des hormones." } }, { "@type": "Question", "name": "Quels symptômes nécessitent d'arrêter le Régulon ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des maux de tête sévères ou des troubles de la vision." } }, { "@type": "Question", "name": "Comment le Régulon prévient-il la grossesse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il empêche l'ovulation et rend la muqueuse utérine moins réceptive aux spermatozoïdes." } }, { "@type": "Question", "name": "Le Régulon est-il efficace pour réguler le cycle menstruel ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut aider à réguler les cycles menstruels irréguliers chez certaines femmes." } }, { "@type": "Question", "name": "Quels conseils pour maximiser l'efficacité du Régulon ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Prenez-le à la même heure chaque jour et évitez les interactions médicamenteuses." } }, { "@type": "Question", "name": "Le Régulon peut-il être utilisé comme traitement hormonal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être prescrit pour traiter des troubles hormonaux comme l'endométriose." } }, { "@type": "Question", "name": "Est-il nécessaire de consulter un médecin avant de commencer le Régulon ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consultation médicale est essentielle pour évaluer les risques et bénéfices." } }, { "@type": "Question", "name": "Comment prendre le Régulon correctement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Prenez un comprimé chaque jour à la même heure pour une efficacité optimale." } }, { "@type": "Question", "name": "Que faire en cas d'oubli d'une pilule ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Prenez la pilule oubliée dès que possible, mais ne doublez pas la dose." } }, { "@type": "Question", "name": "Le Régulon peut-il être pris avec d'autres médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent interférer avec le Régulon, consultez un médecin." } }, { "@type": "Question", "name": "Combien de temps peut-on prendre le Régulon ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il peut être pris pendant plusieurs années, mais un suivi médical est nécessaire." } }, { "@type": "Question", "name": "Le Régulon protège-t-il contre les IST ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, le Régulon ne protège pas contre les infections sexuellement transmissibles." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du Régulon ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des caillots sanguins, AVC ou hypertension." } }, { "@type": "Question", "name": "Comment reconnaître un caillot sanguin lié au Régulon ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs soudaines dans la jambe, gonflement ou rougeur peuvent indiquer un caillot." } }, { "@type": "Question", "name": "Le Régulon augmente-t-il le risque de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent un risque légèrement accru de cancer du sein, mais les données sont variées." } }, { "@type": "Question", "name": "Quels signes d'AVC doivent alerter ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête soudains, troubles de la parole ou paralysie d'un côté du corps." } }, { "@type": "Question", "name": "Le Régulon peut-il causer des problèmes de foie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles hépatiques peuvent survenir, surtout chez les femmes avec antécédents." } }, { "@type": "Question", "name": "Qui devrait éviter le Régulon ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes avec des antécédents de caillots sanguins ou AVC devraient l'éviter." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il l'utilisation du Régulon ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de complications cardiovasculaires avec le Régulon." } }, { "@type": "Question", "name": "Les femmes obèses doivent-elles être prudentes avec le Régulon ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut augmenter le risque de complications liées au Régulon." } }, { "@type": "Question", "name": "Les antécédents familiaux de cancer influencent-ils le choix ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer peuvent nécessiter une évaluation plus approfondie." } }, { "@type": "Question", "name": "Le Régulon est-il sûr pour les femmes âgées ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes de plus de 35 ans, surtout fumeuses, doivent consulter un médecin avant de l'utiliser." } } ] } ] }

Sources (10000 au total)

Current treatment status of IgA nephropathy in Japan: a questionnaire survey.

In 2020, the Committee of Clinical Practical Guideline for IgA Nephropathy (IgAN) revised the clinical practice guidelines. Herein, we conducted a questionnaire survey to assess the potential discrepa... A web-based survey of members of the Japanese Society of Nephrology was conducted between November 15 and December 28, 2021.... A total of 217 members (internal physicians: 203, pediatricians: 14) responded to the questionnaire. Of these respondents, 94.0% answered that the clinical practice guidelines were referred to "always... Our questionnaire survey revealed real-world aspects of IgAN treatment in Japan....

Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan.

Taxanes are widely used chemotherapeutic agents that frequently cause nail changes and have a significant impact on patients' quality of life. Despite the prevalence of taxane-induced nail toxicity, l... The questions addressed prophylactic methods, evaluation practices, and treatment approaches for various nail disorders. The questionnaires were distributed on March 1, 2022, with a response deadline ... Of the 120 questionnaires distributed, 88 (73.3%) were returned, and all of them were analyzed. The respondents included 69 physicians (32 oncologists, 26 breast surgeons, 6 dermatologists, 3 obstetri... Our survey revealed that the management of chemotherapy-induced nail changes varies in clinical practice in Japan. These findings emphasize the need for standardized management strategies and further ...

[The Questionnaire Survey of Japanese Practice and Environment for Targeted Radionuclide Therapy in 2021].

Recently, the targeted radionuclide therapy (TRT) was urgently required to adapt the practice and environment because of the implementation of novel therapeutic radiopharmaceuticals such as alpha- and... The massive questionnaire survey, 2 months from October to November 2021, was conducted among nationwide 251 facilities that have performed TRT in the past two years. The alpha- and beta- therapeutic ... The survey response rate was 69.1% (174 facilities). About 75% of these facilities reported that they either follow the guidelines or take their own measures to reduce occupational exposure. The confi... We clarified the Japanese problem for TRT practice and environment by the questionnaire survey. Our findings indicated that the Japanese guidelines and manuals for TRT were not partly followed in the ...

Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.

Telemedicine, or online medical care, has gained considerable attention worldwide. However, it has not been widely adopted in Japan, and the detailed status of received and provided online medical car... This study aims to investigate the current status of online medical care in Japan and the factors limiting its adoption from the perspective of both patients receiving and medical professionals provid... In total, 2 nationwide questionnaire surveys were conducted. The first survey, targeting both patients and healthy individuals, screened approximately 40,000 participants among 13 million people. The ... The response rates among patients and healthy individuals targeted for the screening and main surveys were 92.5% (36,998/40,000) and ˃80% (1312/1478, 88.77%; 1281/1522, 84.17%; 404/478, 84.5%; and 222... Our nationwide surveys provided insights into the current status of online medical care in Japan and simultaneously identified several problems and issues related to it, which will be useful in promot...

A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany.

Despite the growing understanding of the carcinogenesis of pelvic high-grade serous carcinoma (HGSC) of the ovary and peritoneum and its precursor lesion serous tubal intraepithelial carcinoma (STIC),... A questionnaire containing 21 questions was developed to explore the clinical experience with patients with the diagnosis of STICs and the diagnostic, surgical and histopathological approaches in Germ... 131 questionnaires (response rate 24.3%) were included in this survey. 45.8% of the respondents had treated one to three STIC patients during their career. 75.6% of the respondents performed opportuni... Our survey highlights significant inconsistency in the management of patients with STIC. Prospective data are urgently needed to elucidate the clinical impact of a STIC lesion and its clinical managem...

Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey.

Management of a clinical condition is patient centric. Interdisciplinary coordination plays an influential role in patient management. Pharmacology deals with the study of drugs. Clinical pharmacology... We set up a survey to assess the perceptions of clinical pharmacologists (CPs) regarding their roles and about clinical pharmacology courses in India. The survey was administered via a Google question... Respondents to the questionnaire were working as CPs. They were either postgraduate in pharmacology (MD pharmacology (doctor of medicine in pharmacology) 60.2%) or had a super-specialization degree in... All the CPs opined that training during the postgraduation course was not sufficient to be qualified as CP. There was no consensus among the CPs on the benefit of existing certification courses in cli...

Validation of the newly developed Advanced Practice Nurse Task Questionnaire: A national survey.

To describe psychometric validation of the newly developed Advanced Practice Nurse Task Questionnaire.... Cross-sectional quantitative study.... The development of the questionnaire followed an adapted version of the seven steps described in the guide by the Association for Medical Education in Europe. A nationwide online survey tested the con... We received 222 questionnaires between January and September 2020. The factor analysis produced a seven-factor solution as suggested in Hamric's model. However, not all item loadings aligned with the ... A precise assessment of advanced practice nurse tasks is crucial in clinical practice and in research as it may be a basis for further refinement, implementation and evaluation of roles.... The Advanced Practice Nurse Task Questionnaire is the first valid tool to assess tasks according to Hamric's model of competencies independently of the role or the setting. Additionally, it distinguis... The STARD 2015 guideline was used to report the study.... No patient or public contribution....

Attitude and Needs Toward MTM Applications of Chronic Disease in China: A Questionnaire Survey.

Chronic diseases are characterized by high incidence, long-term medication, and complex types of medication. There are also many corresponding medication therapy management (MTM) applications on the m... From August 2019 to December 2019, we created a questionnaire to have knowledge of user needs, preferences, and expectations for MTM applications among 302 chronic patients in Hunan, Guangdong, and ot... A total of 260 (86.09%) out of 302 patients the respondents were willing to use the MTM applications of chronic disease. The independent influencing factors for using the MTM applications were long-te... The participants are willing to use MTM applications of chronic disease, with a preference for the WeChat applet. Patients tended to use MTM applications if they had a long-term medication history or ...